NHF invites all hematologists, physician assistants, and nurse practitioners who prescribe therapies for individuals with hemophilia and von Willebrand disease to join our “Collaborative Learning Exchange”.

This multi-year training series on emerging clinical issues will include topics in:

  • Novel non-factor treatment modalities for hemophilia A and B
  • Improved clinical management of women diagnosed with a bleeding disorder

What to Expect:
The faculty delivering these interactive ‘learning exchanges’ are experts in the field.  Each session will foster discussion about the unique challenges currently facing hematology prescribers.

The content has been informed by two surveys that examined knowledge and awareness of current clinical practice, and identified the educational gaps and needs for these subject areas among a sample of hematology prescribers.   

How to Participate:
Join your peers in discussing best practices for your patients. These sessions will be held live on a virtual Zoom platform. Participation is limited to foster quality discussions. Pre-register for the first event before the limited slots are all filled.  

 

 

ACCREDITED CONTINUING EDUCATION

In support of improving patient care, this activity has been planned and implemented by University of Nebraska Medical Center and National Hemophilia Foundation. University of Nebraska Medical Center is jointly accredited by the Accreditation Council for Continuing Medical Education (ACCME), the Accreditation Council for Pharmacy Education (ACPE), and the American Nurses Credentialing Center (ANCC), to provide continuing education for the healthcare team.

These activities will provide accredited continuing education credits for physicians, physician assistants, and nurse practitioners.

This training is supported by Cooperative Agreement Number (NU01DD000006), funded by the Centers for Disease Control and Prevention. Its contents are solely the responsibility of the authors and do not necessarily represent the official views of the Centers for Disease Control and Prevention or the Department of Health and Human Services.”